Clinical Trials Browser

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma, Carcinoma, Neoplasm Metastasis, Neoplasms

Adenocarcinoma, Carcinoma, Neoplasms

Adenocarcinoma, Carcinoma, Neoplasms

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma, Neoplasms

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma, Neoplasms

Adenocarcinoma, Carcinoma, Neoplasms

Adenocarcinoma, Neoplasm Metastasis

Adenocarcinoma, Neoplasm Metastasis

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma, Carcinoma, Squamous Cell

Adenocarcinoma, Neoplasms

Adenocarcinoma

Adenocarcinoma, Neoplasms

Adenocarcinoma

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma, Neoplasm Metastasis

Adenocarcinoma

Adenocarcinoma, Neoplasm Metastasis

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

Clinical Trials

A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression

A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC

AAPICO

Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer

BACAP-2

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

BEMAFLOT

A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma

I-FLOAT

TPIAT-01

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

NACRE-2

A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer

Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer

PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy

BACAP

Personalized Vaccine with SOC Chemo Followed by Nivo in Pancreatic Cancer

Beyond TME Origins

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

MIMETIC

Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149

RENMIN-213

REGIRI

HCC and FTC

IMRT-HIT-SNT

DIPLOMA

Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma

A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)

Node

CIPHER

S-1 adjuvant

PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression

LAPC-NGS-A/001

Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma

AVATAR

Combined Thoracoscopic and Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy: A Prospective Trial.

Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

BENEFIT

Role of Perfusion CT in Pancreatic Cancer

PAPAFA

PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma

Efficacy and Safety Evaluation of Sintilimab in Combination With IBI310 as Treatment in Patients With EBV-Positive Gastric Cancer

TOPARP

RegARd-C

Identification of Key Blood Molecular Markers for Immunotherapy